Easton Pharmaceuticals (OTC: EAPH) this morning said it has advanced C$1 million in payments to Alliance Group pursuant to its previously announced closing agreement with Canada-based 124123 Ontario Inc. (O/A – Alliance Group). In turn, Alliance has executed C$8 million aggregate toward the LOI contract on its 90 acres of zoned industrial land. Easton has now paid a total of C$1 million out of the C$1.3 million required to acquire a 50% stake in 45 acres of agriculturally zoned land north of Toronto, Ontario, Canada, as well as a business to cultivate, produce and facilitate the sale of its production of medical and recreational marijuana on a co-managed basis.
To view the full press release, visit: http://cnw.fm/Lm37g
About Easton Pharmaceuticals
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica and together own the exclusive distribution rights in Mexico and Latin America for patented women’s diagnostic / treatment products Gynofit, AmnioSense, VS-Sense and two generic cancer drugs Docetaxel Paclitaxel. Easton / BMV have sub-licensed products Gynofit and AmnioSense with multi-national pharmaceutical company Gedeon Richter Plc of Hungary. The company’s gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs and Cannabidiol extracts. Easton has closed on an agreement to acquire 100% of iBliss Inc., a leading e-liquid vapour producer and distributor with international sales and has entered into a 50 / 50 JV Partnership agreement with Alliance Partners to cultivate, grow, harvest, distribute and sell medical / recreational marijuana for Canada. For more information on Easton visit: www.eastonpharmaceuticalsinc.com
More from CannabisNewsBreaks
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com